PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $93,960 | -27.2% | 10,800 | -0.6% | 0.00% | – |
| Q3 2022 | $129,000 | -17.8% | 10,862 | -0.8% | 0.00% | – |
| Q2 2022 | $157,000 | -32.0% | 10,950 | -1.4% | 0.00% | – |
| Q1 2022 | $231,000 | -7.2% | 11,102 | +2.6% | 0.00% | – |
| Q4 2021 | $249,000 | -95.2% | 10,817 | -93.7% | 0.00% | -100.0% |
| Q3 2021 | $5,147,000 | -30.7% | 172,726 | -20.5% | 0.00% | -50.0% |
| Q2 2021 | $7,422,000 | -6.3% | 217,264 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $7,923,000 | -58.0% | 240,919 | -21.4% | 0.00% | -60.0% |
| Q4 2020 | $18,854,000 | +32.8% | 306,509 | -23.4% | 0.01% | 0.0% |
| Q3 2020 | $14,200,000 | – | 400,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |